As the spread of infectious diseases, current pandemic, and growing antimicrobial resistance (AMR) continues globally, next-generation sequencing (NGS) became a tool to diagnose infectious diseases. The rapid identification of pathogens providing key information on species, strains, genetic variants and geographic origin, NGS and artificial intelligence-based approach enables emerging pathogen and strain identification, patient risk stratification, AMR tracking, clinical interpretation and outcome prediction.
1. Understanding the next-generation sequencing (NGS) and how NGS can be used to fight against infectious diseases and the current pandemic
2. Facilitate in-depth knowledge about harnessing microbial genetic information to develop breakthrough diagnostic and surveillance tools
3. Leverage insights gathered from the microbiome and virome to fight against infectious diseases through the development of precision diagnostics
4. Understanding how NGS and the SARS-CoV-2 viral genome can be used for pandemic surveillance